Shawn P. McCarthy – President & CEO
Shawn has over 20 years of experience in the medical device industry, including more than a decade with Johnson & Johnson.
Before joining Tryton Medical, Shawn was Senior Vice President and General Manager of both Vascular and Oncology Surgery business units at AngioDynamics.
Prior to that, Shawn held a variety of sales and marketing management roles with increasing responsibility at Cordis, Johnson & Johnson, leading to the Worldwide Vice President of Marketing for Cardiology, Endovascular, and Neurovascular. Shawn also served as Worldwide Vice President & Disease State Leader, Carotid & AAA.
Shawn earned both his Bachelors degree in Economics and M.B.A from Syracuse University. Connect directly with Shawn at LinkedIn.
Aaron V. Kaplan, M.D. – Dartmouth Hitchcock Medical Center
Dr. Aaron V. Kaplan is Professor of Medicine and of Community & Family Medicine and Director, Dartmouth Device Development Symposia at Dartmouth Medical School and Director of Research, Cardiac Catheterization Laboratories at the Dartmouth-Hitchcock Medical Center in Lebanon, N.H.
In addition to his clinical responsibilities, Dr. Kaplan supervises cardiology fellows, chairs the Dartmouth Device Development Symposia and lectures regularly at the Tuck School.
Prior to joining the Dartmouth Faculty, Dr. Kaplan was director of Interventional Cardiology at the Palo Alto VA and served on the faculty at Stanford. Dr. Kaplan has more than 40 publications and is on the editorial board of Cardiac Catheterization and Intervention.
Dr. Kaplan has been an active medical device entrepreneur for more than 15 years and has been on the founding team of a number of venture-backed medical device companies including LocalMed and Perclose.
In addition, Dr. Kaplan has consulted to NMT Medical, Guidant Corporation, Johnson & Johnson and was an Entrepreneur-In-Residence at Three Arch Partners. Dr. Kaplan has authored 18 U.S. Patents.
He received a B.S. from Tufts University, M.D. at Wake Forest University, medical training at Northwestern University and cardiology training at Stanford University.
Russell J. Rottiers – Arnerich Messena, Inc.
Russ Rottiers partnered with Arnerich and Messena, Inc. in 2002. This investment firm’s main focus was on the medical device industry.
Russ is also a 30 year veteran of the semiconductor industry including 23 years at Intel Corporation where he managed several business units and programs for the company including components, systems and software for Intel’s Federal Systems Group, Intel Systems Group, Intel’s Workstation Group, and Intel’s Memory Systems Group.
Originally, he managed Intel’s corporate sales activities for several major accounts. He began his semiconductor career at American Microsystems, Inc. as a chemical engineer in their Research and Development Group.
Russ has served on the boards of several companies, including being on the Advisory board for General Motors Institute.
Alejandro Sanchez – Canepa Healthcare Fund
Alejandro is an adviser with Canepa U.S., where he oversees the Canepa Advanced Healthcare Fund’s strategy and investments of its Advanced Healthcare portfolio. Alejandro serves on the Board of Directors of Knome, Tryton Medical, Virgin Mobile Latin America, WAU and No Shame.
Prior to joining Canepa, he was a partner with Hermes Growth Partners and before that, with McKinsey and Company. In the last two years, Alejandro launched Hermes Growth Partners and its Telecom, Media and Technology Fund. Before he spent his tenure with McKinsey and Company working in the telecom, media and technology sectors in a diverse set of countries including Venezuela, Chile, Brazil, Russia, Poland and the United States. He is a Systems Engineer with an MS in Engineering-Economic Systems from Stanford University.
Jay Schmelter – RiverVest Venture Partners
Jay Schmelter is a managing director and co-founder of RiverVest. He focuses on company formation and venture investing in the medical device sector.
Jay has extensive experience in life science venture capital, finance, and industry. Before co-founding RiverVest, he was a principal at Crescendo Ventures, a global venture capital fund, where he led investments for the firm’s life science division.
At Crescendo, he was involved with numerous portfolio companies and founded TissueLink Medical. Prior to his transition to venture capital, Jay was a medical devices research analyst at Piper Jaffray, where his research coverage focused on cardiovascular-related medical device stocks.
He was also a marketing manager for Medtronic, with responsibility for two successful product launches and the marketing activities of two of Medtronic’s U.S. cardiac surgery-related businesses.
He received a B.A. in accounting from Michigan State University and an M.B.A. from the University of Chicago.